← Back to All Filings

Meta CEO Mark Zuckerberg Discloses $21.4M in Planned 10b5-1 Share Sales

Low SignificanceSeptember 29, 2026 at 12:25:24 AM UTC

Meta Platforms, Inc.

$META4CIK: 0001326801

Subscribe to track META

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

=== SEC FORM 4: META PLATFORMS, INC. ($META) ===
Insider: Mark Zuckerberg (COB and CEO, 10% Owner)
Transaction Date: September 24, 2026
Type: Open Market Sales (Rule 10b5-1 Plan)
Shares Sold: 27,474 shares (Class A Common Stock)
Average Price: ~$777.44
Total Consideration: ~$21,359,454
Significance: Low (Routine scheduled sales under 10b5-1 plan)

Comprehensive Analysis

Executive Summary

On September 28, 2026, a Form 4 filing was submitted on behalf of Mark Zuckerberg, Chairman and Chief Executive Officer of Meta Platforms, Inc. ($META). The filing discloses transactions executed on September 24, 2026, comprising the conversion of 17,140 shares of Class B Common Stock to Class A Common Stock and the subsequent open-market sale of 27,474 shares of Class A Common Stock across multiple entities for an aggregate value of approximately $21.36 million.

Transaction Details

All reported sales were executed pursuant to pre-established Rule 10b5-1 trading plans adopted on January 31, 2026:

  1. CZI Holdings, LLC:

    • Converted 17,140 shares of Class B Common Stock into 17,140 shares of Class A Common Stock at $0 per share.
    • Sold 17,140 shares of Class A Common Stock in multiple tranches at weighted-average prices ranging from $775.3906 to $779.3263 per share, generating gross proceeds of approximately $13.33 million.
    • Following the sales, CZI Holdings, LLC retained 0 shares of Class A Common Stock and 100,102,127 shares of Class B Common Stock.
  2. Chan Zuckerberg Biohub, Inc.:

    • Sold 10,334 shares of Class A Common Stock in multiple tranches at weighted-average prices ranging from $775.3185 to $779.2765 per share, generating gross proceeds of approximately $8.03 million.
    • The reporting person exercises voting and investment power over these shares but disclaims pecuniary interest.
    • CZ Biohub held 1,220,703 shares of Class A Common Stock following the reported transactions.

Strategic & Market Significance

  • Routine Nature: These dispositions were executed strictly in accordance with a Rule 10b5-1 trading plan established on January 31, 2026, mitigating concerns regarding opportunistic or material non-public information trading.
  • Significance Assessment: Rated Low. The combined sale of 27,474 shares represents a fraction of 1% of Mark Zuckerberg's total voting control and aggregate beneficial equity interest across various entities (which exceeds 290 million Class B shares).
  • Impact: No operational or governance changes are implied, as the transactions represent ongoing philanthropic and planned estate liquidity programs.
Topics:#META#MetaPlatforms#MarkZuckerberg#InsiderTrading#Form4

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.